Amsalih, Norsida .
HRN: 22-59-55 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
04/29/2023
CIPROFLOXACIN 500MG (TAB)
04/29/2023
05/06/2023
PO
1 Tab
BID
G1P1 (1001) SP NSVD With Laceration And Repair
Waiting Final Action
Indication: Empiric Type of Infection: Reproductive Tract Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes